Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 237-731-1 | 11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione | 13951-70-7 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Not Classified | 4 |  |
|||||||||
| Repr. 2 | H361 (May produce cle...) | H361 |
GHS08 Wng |
State/Form
|
3 | |
View details | ||||
| Repr. 2 | H361 (Suspected of da...) | H361 (Suspected of da...) |
GHS08 Wng |
17 | View details | ||||||
| Repr. 1A | H360 (H360Df) | H360 (H360Df) |
GHS08 Dgr |
State/Form
|
9 | View details | |||||
| Lact. | H362 | H362 | |||||||||
| STOT RE 2 | H373 (no data) (inhalation) | H373 | |||||||||
| Skin Sens. 1 | H317 | H317 |
GHS07 GHS08 Dgr |
3 | View details | ||||||
| Repr. 2 | H361 (H361d) | H361 (H361d) | |||||||||
| STOT RE 1 | H372 (other:Kidney, e...) | H372 | |||||||||
| STOT RE 1 | H372 (Kidney, eye, ad...) | H372 | |||||||||
| H302 |
GHS07 GHS08 Wng |
1 | View details | ||||||||
| H373 | |||||||||||
| H361fd |
GHS08 Wng |
1 | View details | ||||||||
Number of Aggregated Notifications: 7